New Releases from NCBI BookshelfNivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal).Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal).
Post Content
Uncategorized
New Releases from NCBI BookshelfTYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal).TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal).
Post Content
Uncategorized
New Releases from NCBI BookshelfInterventions for Mental Health in Persons With Intellectual Disability: A Scoping Review [Internet].Interventions for Mental Health in Persons With Intellectual Disability: A Scoping Review [Internet].
Treatment of mental health disorders is a concern for individuals with intellectual disability (ID) and their caregivers. This scoping review
Uncategorized
New Releases from NCBI BookshelfTucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies.Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies.
Post Content
Uncategorized
New Releases from NCBI BookshelfAvelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy.Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy.
Post Content
Uncategorized
New Releases from NCBI BookshelfPerfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS).Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS).
This volume of the IARC Monographs provides evaluations of the carcinogenicity of two agents, perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid
Uncategorized
New Releases from NCBI BookshelfEffects of pharmacological and non-pharmacological interventions for the management of sleep problems in people with fibromyalgia: a multi-methods evidence synthesis.Effects of pharmacological and non-pharmacological interventions for the management of sleep problems in people with fibromyalgia: a multi-methods evidence synthesis.
Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain. Sleep problems are reported by 92% of people living with
Uncategorized
New Releases from NCBI BookshelfPramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial.
There are limited options currently recommended in National Institute for Health and Care Excellence guidelines for the treatment of bipolar
